DermTech Reports First-Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
DermTech (DMTK) Misses Q1 EPS by 11c
May 4, 2023 4:42 PM EDTDermTech (NASDAQ: DMTK) reported Q1 EPS of ($1.02), $0.11 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on DermTech (DMTK) click here.
... More